Differentiating Oral Potassium Binders: Mechanism, Onset, and Sodium Load
James Burton, DM, FRCP
Ellie Kelepouris, MD, FACP, FAHA
From Lab Alert to Action Plan: Monitoring Potassium Without Undermining Cardiorenal Protection
Pauline A. Swift, PhD
Hyperkalemia as a Barrier to GDMT: Why “Stopping GDMT” Is Often the Wrong Reflex
Nihar R. Desai, MD, MPH
Potassium Binders to Optimize GDMT Therapy in HFrEF
CKD, Diabetes, and Albuminuria: Keeping Kidney-Protective Therapy on Board Despite Hyperkalemia
Personalized Treatment Strategies for Hyperkalemia: Bridging Evidence and Clinical Practice Needs
The Edema Question: Selecting a Potassium Binder in Patients With HF or Congestion
The Binder Selection Playbook: Matching the Right Strategy to the Right Patient
The Potassium Shift: Individualizing Hyperkalemia Management With Modern Oral Potassium Binders
Engaging Patients With Heart Failure and Chronic Hyperkalemia: Shared Decision-Making to Support Guideline-Directed Medical Therapy
Gianluigi Savarese, MD, PhD, FESC, FHFA
Ready, Set, Act! Opportunities to Address Persistent Unmet Needs in Patients With HFrEF: A Case-Based Discussion
Carolyn Lam, MD, PhD
Stephen J. Greene, MD
Unblocking Clinical Inertia: The CMI Era in oHCM Care
Iacopo Olivotto, MD
Elena Arbelo
Silvia Aguiar
Beyond Steroidal MRAs: The Nonsteroidal MRA Lens in HF
Maria Pabon, MD
Robert J. Mentz, MD, FHFSA, FACC
The Ambulatory HFrEF Blind Spot: Proactively Reducing CV Mortality Risk Despite Optimized GDMT
Javed Butler, MD
Prof. Dr. Johann Bauersachs
GDMT Is Working Fine, so Why Add More Therapies for Patients With HFrEF?
Missing the Window in Ambulatory Patients With HFrEF on GDMT: Strategies for CV Risk Reduction
Loading...
We're glad to see you're enjoying PACE-CME… but how about a more personalized experience?
Press cancel to remain on PACE-CME. Press the link below or the continue button to keep going.